Association between alpha-synuclein (SNCA) rs11931074 variability and susceptibility to Parkinson’s disease: an updated meta-analysis of 41,811 patients

  • Bingying Du
  • Qiang Xue
  • Caiquan Liang
  • Cunxiu Fan
  • Meng Liang
  • Yanbo Zhang
  • Xiaoying BiEmail author
  • Lijun HouEmail author
Review Article


Background and objectives

Parkinson’s disease (PD) is one of the most common forms of neurodegenerative disorders, and its etiology remains unclear. Single nucleotide polymorphisms (SNPs) of alpha-synuclein (SNCA) have been found to be significantly associated with PD risk. In particular, the variant rs11931074 was found in one meta-analysis to appear to play a role in the occurrence of PD. This finding has been questioned in subsequent studies, however. The aim of this study was to determine the relationship between PD risk and rs11931074 polymorphism.


We performed a systematic online search, including PubMed, Web of Science, EMBASE, Cochrane Library, and CNKI (China National Knowledge Infrastructure), aiming to identify case–control studies looking at the role of rs11931074 in PD. We performed calculations of pooled odds ratio (OR) and 95% confidence interval (95% CI) to assess the associations, and subgroup meta-analyses to verify differences between various ethnicities of different study populations.


A total of 13 studies involving 13,403 cases and 28,408 controls met the inclusion criteria after assessment by two reviewers. Overall, there exists significant associations between SNCA rs11931074 polymorphism and the risk of PD under five genetic models (allele contrast model: T vs. G, OR = 1.28, 95% CI = 1.12–1.45, P = 0.0001; homozygote model: TG vs. GG, OR = 1.55, 95% CI = 1.17–2.05, P = 0.002; heterozygote model (TT vs. GG, OR = 1.23, 95% CI = 1.05–1.42, P = 0.009; dominant model: TG+TT vs. GG: OR = 1.25, 95% CI = 1.05–1.50, P = 0.01 and recessive model: TT vs. TG+GG: OR = 1.40, 95% CI = 1.18–1.68, P = 0.0002). When ethnicities were stratified, significant associations were found in the allelic, homozygote, and recessive models for Asians, and in the allelic model for Caucasians.


SNCA rs11931074 polymorphism is found to be associated with PD risk and this risk appears to be influenced by genetic status and ethnicity.


SNCA Polymorphism Parkinson’s disease Meta-analysis 


Funding information

This project was funded by the National Natural Science Foundation of China (grant number 81571299).

Compliance with ethical standards

This study was carried out in accordance with the recommendations of the Ethics Committee of Second Military Medical University.

Conflict of interest

The authors declare that they have no conflict of interest


  1. 1.
    Jankovic J (2008) Parkinson’s disease and movement disorders: moving forward. Lancet Neurol 7:9–11. CrossRefPubMedGoogle Scholar
  2. 2.
    Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA (2016) Time trends in the incidence of Parkinson disease. JAMA Neurol 73:981–989. CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Hirsch L, Jette N, Frolkis A, Steeves T, Pringsheim T (2016) The incidence of Parkinson’s disease: a systematic review and meta-analysis. Neuroepidemiology 46:292–300. CrossRefPubMedGoogle Scholar
  4. 4.
    Muangpaisan W, Hori H, Brayne C (2009) Systematic review of the prevalence and incidence of Parkinson’s disease in Asia. J Epidemiol 19:281–293. CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Zou YM, Liu J, Tian ZY, Lu D, Zhou YY (2015) Systematic review of the prevalence and incidence of Parkinson’s disease in the People’s Republic of China, Neuropsychiatr. Dis Treat 11:1467–1472. CrossRefGoogle Scholar
  6. 6.
    Goswami P, Joshi N, Singh S (2017) Neurodegenerative signaling factors and mechanisms in Parkinson’s pathology. Toxicol in Vitro 13:30157–30151. CrossRefGoogle Scholar
  7. 7.
    Han W, Liu Y, Mi Y, Zhao J, Liu D, Tian D (2015) Alpha-synuclein (SNCA) polymorphisms and susceptibility to Parkinson’s disease: a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 168B:123–134. CrossRefPubMedGoogle Scholar
  8. 8.
    Kim CY, Alcalay RN (2017) Genetic forms of Parkinson’s disease. Semin Neurol 37:135–146. CrossRefPubMedGoogle Scholar
  9. 9.
    Winkler S, Hagenah J, Lincoln S, Heckman M, Haugarvoll K, Lohmann HK, Kostic V, Farrer M, Klein C (2007) alpha-Synuclein and Parkinson disease susceptibility. Neurology 69:1745–1750. CrossRefPubMedGoogle Scholar
  10. 10.
    Elbaz A, Elbaz A, Ross OA et al (2011) Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. Ann Neurol 69:778–792. CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Hu Y, Tang B, Guo J, Wu X, Sun Q, Shi C, Hu L, Wang C, Wang L, Tan L, Shen L, Yan X, Zhang H (2012) Variant in the 3' region of SNCA associated with Parkinson’s disease and serum α-synuclein levels. J Neurol 259:497–504. CrossRefPubMedGoogle Scholar
  12. 12.
    Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C, Kubo M, Kawaguchi T, Tsunoda T, Watanabe M, Takeda A, Tomiyama H, Nakashima K, Hasegawa K, Obata F, Yoshikawa T, Kawakami H, Sakoda S, Yamamoto M, Hattori N, Murata M, Nakamura Y, Toda T (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson’s disease. Nat Genet 41:1303–1307. CrossRefPubMedGoogle Scholar
  13. 13.
    Tan EK, Kwok HH, Tan LC, Zhao WT, Prakash KM, Au WL, Pavanni R, Ng YY, Satake W, Zhao Y, Toda T, Liu JJ (2010) Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus. Neurology 75:508–512. CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Shahmohammadibeni N, Rahimi AS, Jamshidi J et al (2016) The analysis of association between SNCA, HUSEYO and CSMD1 gene variants and Parkinson's disease in Iranian population. Neurol Sci 37:731–736. CrossRefPubMedGoogle Scholar
  15. 15.
    Chen Y, Wei QQ, Ou R, Cao B, Chen X, Zhao B, Guo X, Yang Y, Chen K, Wu Y, Song W, Shang HF (2015) Genetic variants of SNCA are associated with susceptibility to Parkinson’s disease but not amyotrophic lateral sclerosis or multiple system atrophy in a Chinese population. PLoS One 10:e0133776. CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Chung SJ, Jung Y, Hong M, Kim MJ, You S, Kim YJ, Kim J, Song K (2013) Alzheimer's disease and Parkinson’s disease genome-wide association study top hits and risk of Parkinson’s disease in Korean population. Neurobiol Aging 34:2695.e1–2695.e7. CrossRefGoogle Scholar
  17. 17.
    Liu J, Xiao Q, Wang Y, Xu ZM, Wang Y, Yang Q, Wang G, Tan YY, Ma JF, Zhang J, Huang W, Chen SD (2013) Analysis of genome-wide association study-linked loci in Parkinson’s disease of Mainland China. Mov Disord 28:1892–1895. CrossRefPubMedGoogle Scholar
  18. 18.
    Wu-Chou YH, Chen YT, Yeh TH, Chang HC, Weng YH, Lu CS (2013) Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: a replication study in a Taiwanese cohort. Parkinsonism Relat Disord 19:251–255. CrossRefPubMedGoogle Scholar
  19. 19.
    Ross OA, Gosal D, Stone JT, Lincoln SJ, Heckman MG, Irvine GB, Johnston JA, Gibson JM, Farrer MJ, Lynch T (2007) Familial genes in sporadic disease: Common variants of α-synuclein gene associate with Parkinson’s disease, Mech, Ageing. Dev. 128:378–382. CrossRefGoogle Scholar
  20. 20.
    Campelo CLC, Cagni FC, de Siqueira Figueredo D, Oliveira LG Jr, Silva-Neto AB, Macedo PT, Santos JR, Izidio GS, Ribeiro AM, de Andrade TG, de Oliveira Godeiro C Jr, Silva RH (2017) Variants in SNCA gene are associated with Parkinson’s disease risk and cog- nitive symptoms in a Brazilian sample. Front Aging Neurosci 9:198. CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Guo JF, Li K, Yu RL, Sun QY, Wang L, Yao LY, Jiang H, Yan XX, Pan Q, Xia K, Tang BS (2015) Polygenic determinants of Parkinson’s disease in a Chinese population. Neurobiol Aging 36:1765.e1761–1765.e1766. CrossRefGoogle Scholar
  22. 22.
    Zheng J, Yang X, Zhao Q, Tian S, Huang H, Chen Y, Xu Y (2017) Association between gene polymorphism and depression in Parkinson’s disease: a case-control study. J Neurol Sci 375:231–234. CrossRefPubMedGoogle Scholar
  23. 23.
    Zheng J, Yang X, Zhao Q, Tian S, Huang H, Chen Y, Xu Y (2017) Festination correlates with SNCA polymorphism in Chinese patients with Parkinson’s disease. Parkinsons Dis 2017:3176805. CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Heckman MG, Elbaz A, Soto AI, Serie DJ, Aasly JO, Annesi G et al (2014) Protective effect of LRRK2 p.R1398H on risk of Parkinson’s disease is independent of MAPT and SNCA variants. Neurobiol Aging 35:266.e5–266.e14. CrossRefGoogle Scholar
  25. 25.
    Liu X, Zhu R, Xiao TL, Li Q, Zhu Y, He ZY (2018) An updated analysis with 45,078 subjects confirms the association between SNCA rs11931074 and Parkinson’s disease. Neurol Sci 39:2061–2069. CrossRefPubMedGoogle Scholar
  26. 26.
    Mortezaei Z, Lanjanian H, Masoudi NA (2017) Candidate novel long noncoding RNAs, MicroRNAs and putative drugs for Parkinson’s disease using a robust and efficient genome-wide association study. Genomics. 109:158–164. CrossRefPubMedGoogle Scholar

Copyright information

© Fondazione Società Italiana di Neurologia 2019

Authors and Affiliations

  1. 1.Department of Neurology, Shanghai Changhai HospitalSecond Military Medical UniversityShanghaiChina
  2. 2.Department of NeurologyGeneral Hospital of Central Theater Command of Chinese People’s Liberation ArmyWuhanChina
  3. 3.Department of Neurosurgery, Shanghai Eastern Hepatobiliary Surgery HospitalNaval Medical UniversityShanghaiChina
  4. 4.Department of Otolaryngology-Head and Neck Surgery, Changzheng HospitalSecond Military Medical UniversityShanghaiChina
  5. 5.Department of Psychiatry, College of MedicineUniversity of SaskatchewanSaskatoonCanada
  6. 6.Department of Neurosurgery, Shanghai Neurosurgical Institute, Changzheng HospitalSecond Military Medical UniversityShanghaiChina

Personalised recommendations